Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The side effects
The FDA has received adverse event reports, some requiring hospitalization, involving dosing errors in which patients administered five to twenty times their intended dose, due to unfamiliarity with vial-to-syringe measurement and confusion between units
Unlike oral supplements, injections bypass the digestive system entirely, offering faster delivery and greater bioavailability
The FDA classified BPC-157 as a Category 2 bulk drug substance in 2023, meaning it cannot be compounded by commercial pharmaceutical companies and there is insufficient evidence regarding potential human harm
US$ 23.26
US$ 26.75
US$ 29.48
US$ 21.19
